Luis Rios-Nogales

Dr. Luis Rios-Nogales is a medical doctor who currently serves as the Chief Medical Officer at ILiAD Biotechnologies. Luis has also held positions at Università degli Studi di Padova, Rational Vaccines, Università degli Studi di Siena, and Takeda. At Takeda, they were responsible for global development and delivery of vaccines. Luis has also served on the editorial board of the International eJournal of Cardiology and Therapeutic Advances in Drug Safety. In addition, they were the president of Santi Medical Inc. from 2013 to 2015. Dr. Rios-Nogales is a member of the National Theirpanic Life Sciences Society and has been active in the society since 2011.

Luis Rios-Nogales started their educational career by obtaining an MD from Ludwig-Maximilians-Universität München. Luis then specialized in neurosurgery at the University of Tübingen. After working for a number of years, they decided to return to school to get their MBA from the Haslam College of Business at the University of Tennessee. Luis then completed their PhD Magna cum laude from Ludwig-Maximilians-Universität München. Finally, they obtained their HS from Deutsche Schule Alexander von Humboldt Lima Peru.

Some of their coworkers include Ken Solovay - Chief Operating Officer, Anil Vaidya - Senior Director, Scientific & Regulatory Writing, Communications, and Theressa Creighton - Senior Clinical Project Manager. Their manager is Keith Rubin, Founder & CEO.